| Year |
Citation |
Score |
| 2019 |
Kano M, Hsu JY, Saatcioglu HD, Nagykery N, Zhang L, Morris Sabatini ME, Donahoe PK, Pépin D. Neoadjuvant Treatment With Müllerian-Inhibiting Substance Synchronizes Follicles and Enhances Superovulation Yield. Journal of the Endocrine Society. 3: 2123-2134. PMID 31687639 DOI: 10.1210/Js.2019-00190 |
0.337 |
|
| 2019 |
Saatcioglu HD, Kano M, Horn H, Zhang L, Samore W, Nagykery N, Meinsohn MC, Hyun M, Suliman R, Poulo J, Hsu J, Sacha C, Wang D, Gao G, Lage K, ... ... Donahoe PK, et al. Single-cell sequencing of neonatal uterus reveals an endometrial progenitor indispensable for fertility. Elife. 8. PMID 31232694 DOI: 10.7554/Elife.46349.001 |
0.375 |
|
| 2018 |
Pépin D, Sabatini ME, Donahoe PK. Müllerian inhibiting substance/anti-Müllerian hormone as a fertility preservation agent. Current Opinion in Endocrinology, Diabetes, and Obesity. 25: 399-405. PMID 30320617 DOI: 10.1097/Med.0000000000000442 |
0.303 |
|
| 2018 |
Hsu JY, James KE, Bormann CL, Donahoe PK, Pépin D, Sabatini ME. Mullerian-inhibiting substance/anti-Mullerian hormone as a predictor of preterm birth in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. PMID 30239805 DOI: 10.1210/Jc.2018-01320 |
0.309 |
|
| 2018 |
Dubreuil O, Barret JM, Mohan R, Pugnière M, Pepin D, Desigaud D, McDowell W, Manin A, Camper N, Nicolas A, Donahoe PK, Prost JF. Abstract 1779: Anti-Müllerian hormone type II receptor (AMHRII), a cancer target for GM103, a novel antibody-drug conjugate (ADC) Cancer Research. 78: 1779-1779. DOI: 10.1158/1538-7445.Am2018-1779 |
0.325 |
|
| 2017 |
Park SH, Chung YJ, Song JY, Kim SI, Pépin D, MacLaughlin DT, Donahoe PK, Kim JH. Müllerian inhibiting substance inhibits an ovarian cancer cell line via β-catenin interacting protein deregulation of the Wnt signal pathway. International Journal of Oncology. PMID 28197641 DOI: 10.3892/Ijo.2017.3874 |
0.348 |
|
| 2017 |
Kano M, Sosulski AE, Zhang L, Saatcioglu HD, Wang D, Nagykery N, Sabatini ME, Gao G, Donahoe PK, Pépin D. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 28137855 DOI: 10.1073/Pnas.1620729114 |
0.318 |
|
| 2016 |
Donahoe PK, Longoni M, High FA. Polygenic Causes of Congenital Diaphragmatic Hernia Produce Common Lung Pathologies: A Multimodal War on Congenital Diaphragmatic Hernia. The American Journal of Pathology. PMID 27565037 DOI: 10.1016/J.Ajpath.2016.07.006 |
0.301 |
|
| 2016 |
Beck TN, Korobeynikov VA, Kudinov AE, Georgopoulos R, Solanki NR, Andrews-Hoke M, Kistner TM, Pépin D, Donahoe PK, Nicolas E, Einarson MB, Zhou Y, Boumber Y, Proia DA, Serebriiskii IG, et al. Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer. Cell Reports. PMID 27396341 DOI: 10.1016/J.Celrep.2016.06.043 |
0.315 |
|
| 2016 |
Basal E, Ayeni T, Zhang Q, Langstraat C, Donahoe PK, Pepin D, Yin X, Leof E, Cliby W. Patterns of Müllerian inhibiting substance type II and candidate type I receptors in epithelial ovarian cancer. Current Molecular Medicine. PMID 26917267 DOI: 10.2174/1566524016666160225151131 |
0.353 |
|
| 2016 |
Pepin D, Sosulski A, Horn H, Zhang L, Coletti C, Vathipadiekal v, Castro CM, Birrer MJ, Nagano O, Saya H, Lage K, Donahoe PK. Abstract B26: Cell surface expression of CD44v8-10 is associated with good prognosis while cleaved extracellular domain is a marker of poor prognosis in high-grade serous epithelial ovarian cancer. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B26 |
0.311 |
|
| 2015 |
Pépin D, Sosulski A, Zhang L, Wang D, Vathipadiekal V, Hendren K, Coletti CM, Yu A, Castro CM, Birrer MJ, Gao G, Donahoe PK. AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 26216943 DOI: 10.1073/Pnas.1510604112 |
0.352 |
|
| 2015 |
Chung YJ, Kim HJ, Park SH, Yoon JH, Kim MR, Nam SW, MacLaughlin DT, Donahoe PK, Kim JH. Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis. International Journal of Oncology. 46: 2039-46. PMID 25760378 DOI: 10.3892/Ijo.2015.2920 |
0.361 |
|
| 2015 |
Pepin D, Sosulski A, Hendren K, Zhang LH, Nicolaou F, Wang D, Gao G, Donahoe PK. Abstract AS25: An adeno-associated virus (AAV) 9 vector delivering modified human mullerian inhibiting substance (MIS) as a gene therapy for ovarian cancer Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-As25 |
0.349 |
|
| 2014 |
Kim JH, MacLaughlin DT, Donahoe PK. Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors. Obstetrics & Gynecology Science. 57: 343-57. PMID 25264524 DOI: 10.5468/Ogs.2014.57.5.343 |
0.393 |
|
| 2014 |
Park JH, Tanaka Y, Arango NA, Zhang L, Benedict LA, Roh MI, Donahoe PK, Teixeira JM. Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression. Developmental Biology. 386: 227-36. PMID 24362065 DOI: 10.1016/J.Ydbio.2013.12.015 |
0.357 |
|
| 2013 |
Arango NA, Li L, Dabir D, Nicolau F, Pieretti-Vanmarcke R, Koehler C, McCarrey JR, Lu N, Donahoe PK. Meiosis I arrest abnormalities lead to severe oligozoospermia in meiosis 1 arresting protein (M1ap)-deficient mice Biology of Reproduction. 88. PMID 23269666 DOI: 10.1095/Biolreprod.111.098673 |
0.323 |
|
| 2013 |
Pepin D, Hoeng M, Nicolaou F, Hendren K, Benedict L, Sosulski A, Al-Moujahed A, Vavvas D, Donahoe PK. Abstract A42: An albumin leader sequence coupled with a cleavage site modification enhances the yield of recombinant c-terminal Mullerian inhibiting substance Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A42 |
0.322 |
|
| 2012 |
Namkung J, Song JY, Jo HH, Kim MR, Lew YO, Donahoe PK, MacLaughlin DT, Kim JH. Müllerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis Journal of Clinical Endocrinology and Metabolism. 97: 3224-3230. PMID 22761458 DOI: 10.1210/Jc.2012-1538 |
0.38 |
|
| 2012 |
Song JY, Jo HH, Kim MR, Lew YO, Ryu KS, Cha JH, Kang CS, Donahoe PK, MacLaughlin DT, Kim JH. Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer International Journal of Oncology. 40: 2013-2021. PMID 22344630 DOI: 10.3892/Ijo.2012.1370 |
0.33 |
|
| 2012 |
Meirelles K, Benedict LA, Dombkowski D, Pepin D, Preffer FI, Teixeira J, Tanwar PS, Young RH, MacLaughlin DT, Donahoe PK, Wei X. Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance. Proceedings of the National Academy of Sciences of the United States of America. 109: 2358-63. PMID 22308459 DOI: 10.1073/Pnas.1120733109 |
0.33 |
|
| 2011 |
Hwang SJ, Suh MJ, Yoon JH, Kim MR, Ryu KS, Nam SW, Donahoe PK, Maclaughlin DT, Kim JH. Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells. International Journal of Oncology. 39: 811-20. PMID 21573503 DOI: 10.3892/Ijo.2011.1042 |
0.322 |
|
| 2011 |
Chang HL, Pieretti-Vanmarcke R, Nicolaou F, Li X, Wei X, MacLaughlin DT, Donahoe PK. Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines. Gynecologic Oncology. 120: 128-34. PMID 21056908 DOI: 10.1016/J.Ygyno.2010.09.017 |
0.354 |
|
| 2010 |
Wei X, Dombkowski D, Meirelles K, Pieretti-Vanmarcke R, Szotek PP, Chang HL, Preffer FI, Mueller PR, Teixeira J, MacLaughlin DT, Donahoe PK. Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proceedings of the National Academy of Sciences of the United States of America. 107: 18874-9. PMID 20952655 DOI: 10.1073/Pnas.1012667107 |
0.33 |
|
| 2010 |
Tanwar PS, Zhang L, Tanaka Y, Taketo MM, Donahoe PK, Teixeira JM. Focal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchyme. Proceedings of the National Academy of Sciences of the United States of America. 107: 16142-7. PMID 20805501 DOI: 10.1073/Pnas.1011606107 |
0.327 |
|
| 2010 |
Kantarci S, Ackerman KG, Russell MK, Longoni M, Sougnez C, Noonan KM, Hatchwell E, Zhang X, Pieretti Vanmarcke R, Anyane-Yeboa K, Dickman P, Wilson J, Donahoe PK, Pober BR. Characterization of the chromosome 1q41q42.12 region, and the candidate gene DISP1, in patients with CDH. American Journal of Medical Genetics. Part A. 152: 2493-504. PMID 20799323 DOI: 10.1002/Ajmg.A.33618 |
0.305 |
|
| 2010 |
Chang HL, Senaratne TN, Zhang L, Szotek PP, Stewart E, Dombkowski D, Preffer F, Donahoe PK, Teixeira J. Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium. Reproductive Sciences (Thousand Oaks, Calif.). 17: 158-67. PMID 19805552 DOI: 10.1177/1933719109348924 |
0.31 |
|
| 2010 |
Papakostas TD, Pieretti-Vanmarcke R, Nicolaou F, Thanos A, Trichonas G, Koufomichali X, Anago K, Donahoe PK, Teixeira J, MacLaughlin DT, Vavvas D. Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance Protein Expression and Purification. 70: 32-38. PMID 19755162 DOI: 10.1016/J.Pep.2009.09.004 |
0.361 |
|
| 2009 |
Fujino A, Arango NA, Zhan Y, Manganaro TF, Li X, MacLaughlin DT, Donahoe PK. Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct. Developmental Biology. 325: 351-62. PMID 19013450 DOI: 10.1016/J.Ydbio.2008.10.027 |
0.324 |
|
| 2008 |
Szotek PP, Chang HL, Brennand K, Fujino A, Pieretti-Vanmarcke R, Lo Celso C, Dombkowski D, Preffer F, Cohen KS, Teixeira J, Donahoe PK. Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. Proceedings of the National Academy of Sciences of the United States of America. 105: 12469-73. PMID 18711140 DOI: 10.1073/Pnas.0805012105 |
0.301 |
|
| 2008 |
Renlund N, Pieretti-Vanmarcke R, O'Neill FH, Zhang L, Donahoe PK, Teixeira J. c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction. Endocrinology. 149: 108-15. PMID 17947357 DOI: 10.1210/En.2007-0529 |
0.358 |
|
| 2007 |
Fujino A, Pieretti-Vanmarcke R, Wong A, Donahoe PK, Arango NA. Sexual dimorphism of G-protein subunit Gng13 expression in the cortical region of the developing mouse ovary. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 236: 1991-6. PMID 17497668 DOI: 10.1002/Dvdy.21183 |
0.322 |
|
| 2007 |
Szotek PP, Chang HL, Zhang L, Preffer F, Dombkowski D, Donahoe PK, Teixeira J. Adult mouse myometrial label-retaining cells divide in response to gonadotropin stimulation. Stem Cells (Dayton, Ohio). 25: 1317-25. PMID 17289934 DOI: 10.1634/Stemcells.2006-0204 |
0.308 |
|
| 2006 |
Pieretti-Vanmarcke R, Donahoe PK, Pearsall LA, Dinulescu DM, Connolly DC, Halpern EF, Selden MV, MacLaughlin DT. Mullerian inhibiting substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer Proceedings of the National Academy of Sciences of the United States of America. 103: 17426-17431. PMID 17088539 DOI: 10.1073/Pnas.0607959103 |
0.331 |
|
| 2006 |
Arango NA, Huang TT, Fujino A, Pieretti-Vanmarcke R, Donahoe PK. Expression analysis and evolutionary conservation of the mouse germ cell-specific D6Mm5e gene. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 235: 2613-9. PMID 16881047 DOI: 10.1002/Dvdy.20907 |
0.328 |
|
| 2006 |
Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, MacLaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness Proceedings of the National Academy of Sciences of the United States of America. 103: 11154-11159. PMID 16849428 DOI: 10.1073/Pnas.0603672103 |
0.326 |
|
| 2006 |
Tran TT, Segev DL, Gupta V, Kawakubo H, Yeo G, Donahoe PK, Maheswaran S. Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-kappaB-dependent Smad-independent mechanism. Molecular Endocrinology (Baltimore, Md.). 20: 2382-91. PMID 16740653 DOI: 10.1210/Me.2005-0480 |
0.312 |
|
| 2006 |
Zhan Y, Fujino A, MacLaughlin DT, Manganaro TF, Szotek PP, Arango NA, Teixeira J, Donahoe PK. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression. Development (Cambridge, England). 133: 2359-69. PMID 16687449 DOI: 10.1242/Dev.02383 |
0.362 |
|
| 2006 |
Pieretti-Vanmarcke R, Donahoe PK, Szotek P, Manganaro T, Lorenzen MK, Lorenzen J, Connolly DC, Halpern EF, MacLaughlin DT. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo Clinical Cancer Research. 12: 1593-1598. PMID 16533786 DOI: 10.1158/1078-0432.Ccr-05-2108 |
0.371 |
|
| 2005 |
Gupta V, Carey JL, Kawakubo H, Muzikansky A, Green JE, Donahoe PK, MacLaughlin DT, Maheswaran S. Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model. Proceedings of the National Academy of Sciences of the United States of America. 102: 3219-24. PMID 15728372 DOI: 10.1073/Pnas.0409709102 |
0.315 |
|
| 2005 |
Renaud EJ, MacLaughlin DT, Oliva E, Rueda BR, Donahoe PK. Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance Proceedings of the National Academy of Sciences of the United States of America. 102: 111-116. PMID 15618407 DOI: 10.1073/Pnas.0407772101 |
0.377 |
|
| 2004 |
Arango NA, Pearson EJ, Donahoe PK, Teixeira J. Genomic structure and expression analysis of the mouse testis-specific ribbon protein (Trib) gene. Gene. 343: 221-7. PMID 15563848 DOI: 10.1016/J.Gene.2004.09.014 |
0.307 |
|
| 2004 |
Trbovich AM, Martinelle N, O'Neill FH, Pearson EJ, Donahoe PK, Sluss PM, Teixeira J. Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance. The Journal of Steroid Biochemistry and Molecular Biology. 92: 199-208. PMID 15555913 DOI: 10.1016/J.Jsbmb.2004.07.002 |
0.34 |
|
| 2004 |
Houk CP, Pearson EJ, Martinelle N, Donahoe PK, Teixeira J. Feedback inhibition of steroidogenic acute regulatory protein expression in vitro and in vivo by androgens. Endocrinology. 145: 1269-75. PMID 14630719 DOI: 10.1210/En.2003-1046 |
0.332 |
|
| 2004 |
Salva A, Hardy MP, Wu XF, Sottas CM, MacLaughlin DT, Donahoe PK, Lee MM. Müllerian-Inhibiting Substance Inhibits Rat Leydig Cell Regeneration after Ethylene Dimethanesulphonate Ablation Biology of Reproduction. 70: 600-607. PMID 14585814 DOI: 10.1095/Biolreprod.103.021550 |
0.357 |
|
| 2004 |
Renaud EJ, Oliva E, Rueda B, MacLaughlin D, Donahoe P. Endometrial cancer expresses the Mullerian Inhibiting Substance (MIS) type II receptor and is growth inhibited by MIS Journal of the American College of Surgeons. 199: 82-83. DOI: 10.1016/J.Jamcollsurg.2004.06.001 |
0.39 |
|
| 2003 |
Barbie TU, Barbie DA, MacLaughlin DT, Maheswaran S, Donahoe PK. Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107 Proceedings of the National Academy of Sciences of the United States of America. 100: 15601-15606. PMID 14671316 DOI: 10.1073/Pnas.2636900100 |
0.349 |
|
| 2003 |
Lee MM, Misra M, Donahoe PK, MacLaughlin DT. MIS/AMH in the assessment of cryptorchidism and intersex conditions Molecular and Cellular Endocrinology. 211: 91-98. PMID 14656481 DOI: 10.1016/J.Mce.2003.09.014 |
0.311 |
|
| 2003 |
Donahoe PK, Clarke T, Teixeira J, Maheswaran S, MacLaughlin DT. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications Molecular and Cellular Endocrinology. 211: 37-41. PMID 14656474 DOI: 10.1016/J.Mce.2003.09.009 |
0.378 |
|
| 2003 |
Hoshiya Y, Gupta V, Kawakubo H, Brachtel E, Carey JL, Sasur L, Scott A, Donahoe PK, Maheswaran S. Mullerian inhibiting substance promotes interferon gamma-induced gene expression and apoptosis in breast cancer cells. The Journal of Biological Chemistry. 278: 51703-12. PMID 14532292 DOI: 10.1074/Jbc.M307626200 |
0.318 |
|
| 2003 |
Misra M, MacLaughlin DT, Donahoe PK, Lee MM. The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization Journal of Clinical Endocrinology and Metabolism. 88: 787-792. PMID 12574214 DOI: 10.1210/Jc.2002-020889 |
0.326 |
|
| 2002 |
MacLaughlin DT, Donahoe PK. Mullerian inhibiting substance: An update Advances in Experimental Medicine and Biology. 511: 25-40. PMID 12575754 DOI: 10.1007/978-1-4615-0621-8_3 |
0.34 |
|
| 2002 |
Laurich VM, Trbovich AM, O'Neill FH, Houk CP, Sluss PM, Payne AH, Donahoe PK, Teixeira J. Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation. Endocrinology. 143: 3351-60. PMID 12193547 DOI: 10.1210/En.2001-211352 |
0.345 |
|
| 2002 |
Misra M, MacLaughlin DT, Donahoe PK, Lee MM, Massachusetts. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism Journal of Clinical Endocrinology and Metabolism. 87: 3598-3602. PMID 12161481 DOI: 10.1210/Jcem.87.8.8742 |
0.336 |
|
| 2002 |
Lorenzo HK, Teixeira J, Pahlavan N, Matt Laurich V, Donahoe PK, MacLaughlin DT. New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 766: 89-98. PMID 11820299 DOI: 10.1016/S0378-4347(01)00436-4 |
0.302 |
|
| 2002 |
Segev DL, Hoshiya Y, Hoshiya M, Tran TT, Carey JL, Stephen AE, MacLaughlin DT, Donahoe PK, Maheswaran S. Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 99: 239-44. PMID 11773638 DOI: 10.1073/Pnas.221599298 |
0.304 |
|
| 2001 |
Teixeira J, Maheswaran S, Donahoe PK. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocrine Reviews. 22: 657-674. PMID 11588147 DOI: 10.1210/Edrv.22.5.0445 |
0.372 |
|
| 2001 |
Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Molecular Endocrinology (Baltimore, Md.). 15: 946-59. PMID 11376113 DOI: 10.1210/Mend.15.6.0664 |
0.343 |
|
| 2001 |
Segev DL, Hoshiya Y, Stephen AE, Hoshiya M, Tran TT, MacLaughlin DT, Donahoe PK, Maheswaran S. Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo. The Journal of Biological Chemistry. 276: 26799-806. PMID 11356848 DOI: 10.1074/Jbc.M103092200 |
0.341 |
|
| 2001 |
Trbovich AM, Sluss PM, Laurich VM, O'Neill FH, MacLaughlin DT, Donahoe PK, Teixeira J. Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents Proceedings of the National Academy of Sciences of the United States of America. 98: 3393-3397. PMID 11248089 DOI: 10.1073/Pnas.051632298 |
0.366 |
|
| 2001 |
Stephen AE, Masiakos PT, Segev DL, Vacanti JP, Donahoe PK, MacLaughlin DT. Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo Proceedings of the National Academy of Sciences of the United States of America. 98: 3214-3219. PMID 11248058 DOI: 10.1073/Pnas.051625998 |
0.336 |
|
| 2001 |
Ha TU, Segev DL, Barbie D, Masiakos PT, Tran TT, Dombkowski D, Glander M, Clarke TR, Lorenzo HK, Donahoe PK, Maheswaran S. Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism. The Journal of Biological Chemistry. 275: 37101-9. PMID 10958795 DOI: 10.1074/Jbc.M005701200 |
0.383 |
|
| 2001 |
Sriraman V, Niu E, Matias JR, Donahoe PK, MacLaughlin DT, Hardy MP, Lee MM. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats. Journal of Andrology. 22: 750-758. DOI: 10.1002/J.1939-4640.2001.Tb02577.X |
0.363 |
|
| 2000 |
Morikawa N, Clarke TR, Novina CD, Watanabe K, Haqq C, Weiss M, Roy AL, Donahoe PK. Human mullerian-inhibiting substance promoter contains a functional TFII-I-binding initiator Biology of Reproduction. 63: 1075-1083. PMID 10993829 DOI: 10.1095/Biolreprod63.4.1075 |
0.332 |
|
| 2000 |
Watanabe K, Clarke TR, Lane AH, Wang X, Donahoe PK. Endogenous expression of Müllerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites. Proceedings of the National Academy of Sciences of the United States of America. 97: 1624-1629. PMID 10677509 DOI: 10.1073/Pnas.97.4.1624 |
0.326 |
|
| 1999 |
Teixeira J, Kehas DJ, Antun R, Donahoe PK. Transcriptional regulation of the rat Müllerian inhibiting substance type II receptor in rodent Leydig cells Proceedings of the National Academy of Sciences of the United States of America. 96: 13831-13838. PMID 10570158 DOI: 10.1073/Pnas.96.24.13831 |
0.327 |
|
| 1999 |
Teixeira J, Fynn-Thompson E, Payne AH, Donahoe PK. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level. Endocrinology. 140: 4732-8. PMID 10499532 DOI: 10.1210/Endo.140.10.7075 |
0.386 |
|
| 1999 |
Lee MM, Seah CC, Masiakos PT, Sottas CM, Preffer FI, Donahoe PK, Maclaughlin DT, Hardy MP. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells Endocrinology. 140: 2819-2827. PMID 10342873 DOI: 10.1210/Endo.140.6.6786 |
0.37 |
|
| 1999 |
Morita Y, Manganaro TF, Tao XJ, Martimbeau S, Donahoe PK, Tilly JL. Requirement for phosphatidylinositol-3'-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse. Endocrinology. 140: 941-9. PMID 9927327 DOI: 10.1210/Endo.140.2.6539 |
0.338 |
|
| 1998 |
Lane A, Donahoe P. New insights into mullerian inhibiting substance and its mechanism of action Journal of Endocrinology. 158: 1-6. PMID 9713320 DOI: 10.1677/Joe.0.1580001 |
0.334 |
|
| 1998 |
Losty PD, Vanamo K, Rintala RJ, Donahoe PK, Schnitzer JJ, Lloyd DA. Congenital diaphragmatic hernia--does the side of the defect influence the incidence of associated malformations? Journal of Pediatric Surgery. 33: 507-10. PMID 9537568 DOI: 10.1016/S0022-3468(98)90099-9 |
0.302 |
|
| 1998 |
Gu Z, Nomura M, Simpson BB, Lei H, Feijen A, van den Eijnden-van Raaij J, Donahoe PK, Li E. The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse. Genes & Development. 12: 844-57. PMID 9512518 DOI: 10.1101/Gad.12.6.844 |
0.322 |
|
| 1997 |
Catlin EA, Tonnu VC, Ebb RG, Pacheco BA, Manganaro TF, Ezzell RM, Donahoe PK, Teixeira J. Müllerian Inhibiting Substance Inhibits Branching Morphogenesis and Induces Apoptosis in Fetal Rat Lung. Endocrinology. 138: 790-796. PMID 28199580 DOI: 10.1210/Endo.138.2.4906 |
0.348 |
|
| 1996 |
Kluth D, Losty PD, Schnitzer JJ, Lambrecht W, Donahoe PK. Toward understanding the developmental anatomy of congenital diaphragmatic hernia. Clinics in Perinatology. 23: 655-69. PMID 8982562 DOI: 10.1016/S0095-5108(18)30200-8 |
0.317 |
|
| 1996 |
Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood Journal of Clinical Endocrinology and Metabolism. 81: 571-576. PMID 8636269 DOI: 10.1210/Jcem.81.2.8636269 |
0.356 |
|
| 1996 |
Teixeira J, He WW, Shah PC, Morikawa N, Lee MM, Catlin EA, Hudson PL, Wing J, Maclaughlin DT, Donahoe PK. Developmental Expression of a Candidate Müllerian Inhibiting Substance Type II Receptor Endocrinology. 137: 160-165. PMID 8536608 DOI: 10.1210/Endo.137.1.8536608 |
0.336 |
|
| 1995 |
Haqq CM, King CY, Ukiyama E, Falsafi S, Haqq TN, Donahoe PK, Weiss MA. Molecular basis of mammalian sexual determination: activation of Müllerian inhibiting substance gene expression by SRY. Science (New York, N.Y.). 266: 1494-500. PMID 7985018 DOI: 10.1126/Science.7985018 |
0.337 |
|
| 1995 |
Alles AJ, Losty PD, Donahoe PK, Manganaro TF, Schnitzer JJ. Embryonic cell death patterns associated with nitrofen-induced congenital diaphragmatic hernia. Journal of Pediatric Surgery. 30: 353-8; discussion 35. PMID 7537810 DOI: 10.1016/0022-3468(95)90589-8 |
0.313 |
|
| 1994 |
Hirobe S, Wei Wu He, Gustafson ML, MacLaughlin DT, Donahoe PK. Mullerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or Graafian follicle selection Biology of Reproduction. 50: 1238-1243. PMID 8080912 DOI: 10.1095/Biolreprod50.6.1238 |
0.329 |
|
| 1994 |
Meyers-Wallen VN, Maclaughlin D, Palmer V, Donahoe PK. Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos. Molecular Reproduction and Development. 39: 1-7. PMID 7999353 DOI: 10.1002/Mrd.1080390102 |
0.361 |
|
| 1993 |
Gustafson ML, Lee MM, Asmundson L, MacLaughlin DT, Donahoe PK. Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities Journal of Pediatric Surgery. 28: 439-444. PMID 8468660 DOI: 10.1016/0022-3468(93)90245-G |
0.342 |
|
| 1993 |
Seifer DB, MacLaughlin DT, Penzias AS, Behrman HR, Asmundson L, Donahoe PK, Haning RV, Flynn SD. Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen content. The Journal of Clinical Endocrinology and Metabolism. 76: 711-4. PMID 8445031 DOI: 10.1210/Jcem.76.3.8445031 |
0.323 |
|
| 1993 |
Haqq CM, King CY, Donahoe PK, Weiss MA. SRY recognizes conserved DNA sites in sex-specific promoters. Proceedings of the National Academy of Sciences of the United States of America. 90: 1097-101. PMID 8430080 DOI: 10.1073/Pnas.90.3.1097 |
0.319 |
|
| 1993 |
Taketo T, Saeed J, Manganaro T, Takahashi M, Donahoe PK. Müllerian inhibiting substance production associated with loss of oocytes and testicular differentiation in the transplanted mouse XX gonadal primordium. Biology of Reproduction. 49: 13-23. PMID 8353178 DOI: 10.1095/Biolreprod49.1.13 |
0.322 |
|
| 1993 |
Lee MM, Donahoe PK. Mullerian inhibiting substance: A gonadal hormone with multiple functions Endocrine Reviews. 14: 152-164. PMID 8325249 DOI: 10.1210/Edrv-14-2-152 |
0.372 |
|
| 1993 |
Catlin EA, Ezzell RM, Donahoe PK, Gustafson ML, Son EV, MacLaughlin DT. Identification of a receptor for human müllerian inhibiting substance Endocrinology. 133: 3007-3013. PMID 8243329 DOI: 10.1210/Endo.133.6.8243329 |
0.308 |
|
| 1992 |
Gustafson ML, Lee MM, Scully RE, Moncure AC, Hirakawa T, Goodman A, Muntz HG, Donahoe PK, MacLaughlin DT, Fuller AF. Müllerian Inhibiting Substance as a Marker for Ovarian Sex-Cord Tumor The New England Journal of Medicine. 326: 466-471. PMID 1732773 DOI: 10.1056/Nejm199202133260707 |
0.353 |
|
| 1992 |
Hirobe S, He WW, Lee MM, Donahoe PK. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology. 131: 854-862. PMID 1639028 DOI: 10.1210/Endo.131.2.1639028 |
0.363 |
|
| 1992 |
Donahoe PK. Müllerian inhibiting substance in reproduction and cancer. Molecular Reproduction and Development. 32: 168-172. PMID 1637555 DOI: 10.1002/Mrd.1080320213 |
0.405 |
|
| 1992 |
MacLaughlin DT, Hudson PL, Graciano AL, Kenneally MK, Ragin RC, Manganaro TF, Donahoe PK. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain Endocrinology. 131: 291-296. PMID 1612008 DOI: 10.1210/Endo.131.1.1612008 |
0.313 |
|
| 1992 |
Haqq CM, Lee MM, Tizard R, Wysk M, DeMarinis J, Donahoe PK, Cate RL. Isolation of the rat gene for Mullerian inhibiting substance. Genomics. 12: 665-669. PMID 1572639 DOI: 10.1016/0888-7543(92)90291-Y |
0.324 |
|
| 1992 |
Kim JH, Seibel MM, MacLaughlin DT, Donahoe PK, Ransil BJ, Hametz PA, Richards CJ. The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells The Journal of Clinical Endocrinology and Metabolism. 75: 911-917. PMID 1517385 DOI: 10.1210/Jcem.75.3.1517385 |
0.339 |
|
| 1992 |
Catlin EA, Ezzell RM, Donahoe PK, Manganaro TF, Ebb RG, MacLaughlin DT. Mullerian inhibiting substance binding and uptake. Developmental Dynamics. 193: 295-299. PMID 1511169 DOI: 10.1002/Aja.1001930402 |
0.303 |
|
| 1992 |
Tsuji M, Shima H, Yonemura CY, Brody J, Donahoe PK, Cunha GR. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat. Endocrinology. 131: 1481-1488. PMID 1505479 DOI: 10.1210/Endo.131.3.1505479 |
0.337 |
|
| 1992 |
Lee MM, Cate RL, Donahoe PK, Waneck GL. Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for Mullerian inhibiting substance Endocrinology. 130: 847-853. PMID 1346380 DOI: 10.1210/Endo.130.2.1346380 |
0.314 |
|
| 1991 |
Kuroda T, Lee MM, Ragin RC, Hirobe S, Donahoe PK. Mullerian inhibiting substance production and cleavage is modulated by gonadotropins and steroids Endocrinology. 129: 2985-2992. PMID 1954882 DOI: 10.1210/Endo-129-6-2985 |
0.307 |
|
| 1991 |
Catlin EA, Uitvlugt ND, Donahoe PK, Powell DM, Hayashi M, MacLaughlin DT. Müllerian inhibiting substance blocks epidermal growth factor receptor phosphorylation in fetal rat lung membranes. Metabolism: Clinical and Experimental. 40: 1178-84. PMID 1943746 DOI: 10.1016/0026-0495(91)90213-G |
0.34 |
|
| 1991 |
Meyers-Wallen VN, Manganaro TF, Kuroda T, Concannon PW, MacLaughlin DT, Donahoe PK. The critical period for mullerian duct regression in the dog embryo. Biology of Reproduction. 45: 626-633. PMID 1751638 DOI: 10.1095/Biolreprod45.4.626 |
0.327 |
|
| 1990 |
Catlin EA, Powell SM, Manganaro TF, Hudson PL, Ragin RC, Epstein J, Donahoe PK. Sex-specific fetal lung development and Mullerian inhibiting substance American Review of Respiratory Disease. 141: 466-470. PMID 2301861 DOI: 10.1164/Ajrccm/141.2.466 |
0.345 |
|
| 1990 |
Kuroda T, Lee MM, Haqq CM, Powell DM, Manganaro TF, Donahoe PK. Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes. Endocrinology. 127: 1825-32. PMID 2119293 DOI: 10.1210/Endo-127-4-1825 |
0.315 |
|
| 1990 |
Cate RL, Donahoe PK, MacLaughlin DT. Mullerian-Inhibiting Substance Modern Cell Biology. 12: 179-210. DOI: 10.1007/978-3-642-74781-6_7 |
0.327 |
|
| 1989 |
Meyers-Wallen VN, Lee MM, Manganaro TF, Kuroda T, MacLaughlin DT, Donahoe PK. Mullerian Inhibiting Substance is present in embryonic testes of dogs with Persistent Mullerian Duct Syndrome Biology of Reproduction. 48: 1410-1418. PMID 8318594 DOI: 10.1095/Biolreprod48.6.1410 |
0.354 |
|
| 1989 |
Epstein J, Desjardins EJ, Hudson PL, Donahoe PK. Stainless steel mesh supports high density cell growth and production of recombinant müllerian inhibiting substances. In Vitro Cellular & Developmental Biology – Plant. 25: 213-216. PMID 2921237 DOI: 10.1007/Bf02626181 |
0.301 |
|
| 1989 |
Ueno S, Kuroda T, Maclaughlin DT, Ragin RC, Manganaro TF, Donahoe PK. Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle. Endocrinology. 125: 1060-1066. PMID 2752965 DOI: 10.1210/Endo-125-2-1060 |
0.344 |
|
| 1989 |
Ueno S, Takahashi M, Manganaro TF, Ragin RC, Donahoe PK. Cellular localization of müllerian inhibiting substance in the developing rat ovary. Endocrinology. 124: 1000-1006. PMID 2643506 DOI: 10.1210/Endo-124-2-1000 |
0.316 |
|
| 1989 |
Cigarroa FG, Coughlin JP, Donahoe PK, White MF, Uitvlugt N, MacLaughlin DT. Recombinant human müllerian inhibiting substance inhibits epidermal growth factor receptor tyrosine kinase. Growth Factors (Chur, Switzerland). 1: 179-91. PMID 2560399 DOI: 10.3109/08977198909029127 |
0.313 |
|
| 1988 |
Catlin EA, Manganaro TF, Donahoe PK. Müllerian inhibiting substance depresses accumulation in vitro of disaturated phosphatidylcholine in fetal rat lung American Journal of Obstetrics and Gynecology. 159: 1299-1303. PMID 3189462 DOI: 10.1016/0002-9378(88)90467-X |
0.329 |
|
| 1988 |
Ueno S, Manganaro TF, Donahoe PK. Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro. Endocrinology. 123: 1652-1659. PMID 2456917 DOI: 10.1210/Endo-123-3-1652 |
0.364 |
|
| 1987 |
Meyers-Wallen VN, Donahoe PK, Manganaro T, Patterson DF. Müllerian inhibiting substance in sex-reversed dogs. Biology of Reproduction. 37: 1015-1022. PMID 3689844 DOI: 10.1095/Biolreprod37.4.1015 |
0.327 |
|
| 1986 |
Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP, Fisher RA, Bertonis JM, Torres G, Wallner BP, Ramachandran KL, ... ... Donahoe PK, et al. Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells Cell. 45: 685-698. PMID 3754790 DOI: 10.1016/0092-8674(86)90783-X |
0.308 |
|
| 1986 |
Necklaws EC, LaQuaglia MP, MacLaughlin D, Hudson P, Mudgett-Hunter M, Donahoe PK. Detection of Müllerian inhibiting substance in biological samples by a solid phase sandwich radioimmunoassay. Endocrinology. 118: 791-6. PMID 3753678 DOI: 10.1210/Endo-118-2-791 |
0.319 |
|
| 1986 |
Takahashi M, Hayashi M, Manganaro TF, Donahoe PK. The ontogeny of mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle. Biology of Reproduction. 35: 447-453. PMID 3533170 DOI: 10.1095/Biolreprod35.2.447 |
0.344 |
|
| 1986 |
LaQuaglia M, Shima H, Hudson P, Takahashi M, Donahoe PK. Sertoli Cell Production of Müllerian Inhibiting Substance in Vitro The Journal of Urology. 136: 219-224. PMID 3014167 DOI: 10.1016/S0022-5347(17)44821-X |
0.317 |
|
| 1986 |
Hutson JM, Donahoe PK. The Hormonal-Control Of Testicular Descent Endocrine Reviews. 7: 270-283. PMID 2874985 DOI: 10.1210/Edrv-7-3-270 |
0.312 |
|
| 1986 |
Takahashi M, Koide SS, Donahoe PK. Müllerian inhibiting substance as oocyte meiosis inhibitor. Molecular and Cellular Endocrinology. 47: 225-234. PMID 2428679 DOI: 10.1016/0303-7207(86)90116-4 |
0.355 |
|
| 1985 |
Fuller AF, Krane IM, Budzik GP, Donahoe PK. Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay. Gynecologic Oncology. 22: 135-148. PMID 3932140 DOI: 10.1016/0090-8258(85)90019-8 |
0.348 |
|
| 1985 |
Hutson JM, Donahoe PK, MacLaughlin DT. Steroid modulation of Mullerian duct regression in the chick embryo General and Comparative Endocrinology. 57: 88-102. PMID 3838289 DOI: 10.1016/0016-6480(85)90204-7 |
0.334 |
|
| 1985 |
Hutson JM, Donahoe PK, Budzik GP. Mullerian inhibiting substance: a fetal hormone with surgical implications. Australian and New Zealand Journal of Surgery. 55: 599-605. PMID 2870703 DOI: 10.1111/J.1445-2197.1985.Tb00953.X |
0.36 |
|
| 1985 |
Kamagata S, Donahoe PK. The effect of fibronectin on cholinergic differentiation of the fetal colon. Journal of Pediatric Surgery. 20: 307-314. PMID 2413194 DOI: 10.1016/S0022-3468(85)80209-8 |
0.3 |
|
| 1984 |
Fuller AF, Budzik GP, Krane IM, Donahoe PK. Müllerian inhibiting substance inhibition of a human endometrial carcinoma cell line xenografted in nude mice. Gynecologic Oncology. 17: 124-132. PMID 6546372 DOI: 10.1016/0090-8258(84)90066-0 |
0.346 |
|
| 1984 |
Eil C, Crawford JD, Donahoe PK, Johnsonbaugh RE, Loriaux DL. Fibroblast androgen receptors in patients with genitourinary anomalies. Journal of Andrology. 5: 313-20. PMID 6501082 DOI: 10.1002/J.1939-4640.1984.Tb00795.X |
0.314 |
|
| 1984 |
Ikawa H, Hutson JM, Budzik GP, Donahoe PK. Cyclic adenosine 3',5'-monophosphate modulation of mullerian duct regression. Endocrinology. 114: 1686-1691. PMID 6201348 DOI: 10.1210/Endo-114-5-1686 |
0.323 |
|
| 1984 |
Fallat ME, Hutson JM, Budzik GP, Donahoe PK. Androgen stimulation of nucleotide pyrophosphatase during mullerian duct regression. Endocrinology. 114: 1592-8. PMID 6143657 DOI: 10.1210/Endo-114-5-1592 |
0.36 |
|
| 1984 |
Donahoe PK, Krane I, Bogdén AE, Kamagata S, Budzik GP. Subrenal capsule assay to test the viability of parenterally delivered müllerian inhibiting substance Journal of Pediatric Surgery. 19: 863-869. PMID 6084056 DOI: 10.1016/S0022-3468(84)80386-3 |
0.322 |
|
| 1983 |
Hutson JM, Donahoe PK. Is Mullerian-Inhibiting Substance a Circulating Hormone in the Chick-Quail Chimera?* Endocrinology. 113: 1470-1475. PMID 6688583 DOI: 10.1210/Endo-113-4-1470 |
0.312 |
|
| 1983 |
Budzik GP, Powell SM, Kamagata S, Donahoe PK. Mullerian inhibiting substance fractionation by dye affinity chromatography Cell. 34: 307-314. PMID 6411352 DOI: 10.1016/0092-8674(83)90161-7 |
0.308 |
|
| 1983 |
Fallat ME, Hutson JM, Budzik GP, Donahoe PK. The role of nucleotide pyrophosphatase in Mullerian duct regression. Developmental Biology. 100: 358-64. PMID 6140197 DOI: 10.1016/0012-1606(83)90230-0 |
0.327 |
|
| 1982 |
Robboy SJ, Miller T, Donahoe PK, Jahre C, Welch WR, Haseltine FP, Miller WA, Atkins L, Crawford JD. Dysgenesis of testicular and streak gonads in the syndrome of mixed gonadal dysgenesis: perspective derived from a clinicopathologic analysis of twenty-one cases. Human Pathology. 13: 700-16. PMID 7106733 DOI: 10.1016/S0046-8177(82)80292-X |
0.337 |
|
| 1982 |
Trelstad RL, Hayashi A, Hayashi K, Donahoe PK. The epithelial-mesenchymal interface of the male rat Mullerian duct: Loss of basement membrane integrity and ductal regression Developmental Biology. 92: 27-40. PMID 7106385 DOI: 10.1016/0012-1606(82)90147-6 |
0.303 |
|
| 1982 |
Hayashi A, Donahoe PK, Budzik GP, Trelstad RL. Periductal and matrix glycosaminoglycans in rat Mullerian duct development and regression. Developmental Biology. 92: 16-26. PMID 7106377 DOI: 10.1016/0012-1606(82)90146-4 |
0.339 |
|
| 1982 |
Hutson JM, Ikawa H, Donahoe PK. Estrogen inhibition of mullerian inhibiting substance in the chick embryo Journal of Pediatric Surgery. 17: 953-959. PMID 6897657 DOI: 10.1016/S0022-3468(82)80474-0 |
0.356 |
|
| 1982 |
Fuller AF, Guy S, Budzik GP, Donahoe PK. Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line. The Journal of Clinical Endocrinology and Metabolism. 54: 1051-5. PMID 6895900 DOI: 10.1210/Jcem-54-5-1051 |
0.363 |
|
| 1982 |
Budzik GP, Hutson JM, Ikawa H, Donahoe PK. The Role of Zinc in Miillerian Duct Regression Endocrinology. 110: 1521-1525. PMID 6804204 DOI: 10.1210/Endo-110-5-1521 |
0.302 |
|
| 1981 |
Hutson J, Ikawa H, Donahoe PK. The ontogeny of mullerian inhibiting substance in the gonads of the chicken Journal of Pediatric Surgery. 16: 822-827. PMID 6896069 DOI: 10.1016/S0022-3468(81)80827-5 |
0.348 |
|
| 1981 |
Donahoe PK, Fuller AF, Scully RE, Guy SR, Budzik GP. Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice. Annals of Surgery. 194: 472-80. PMID 6895157 DOI: 10.1097/00000658-198110000-00010 |
0.345 |
|
| 1979 |
Price JM, Donahoe PK, Ito Y. Involution of the female Mullerian duct of the fetal rat in the organ-culture assay for the detection of Mullerian Inhibiting Substance. American Journal of Anatomy. 156: 265-283. PMID 506954 DOI: 10.1002/Aja.1001560207 |
0.331 |
|
| 1979 |
Donahoe PK, Crawford JD, Hendren WH. Mixed gonadal dysgenesis, pathogensis, and management. Journal of Pediatric Surgery. 14: 287-300. PMID 480090 DOI: 10.1016/S0022-3468(79)80486-8 |
0.331 |
|
| 1979 |
Donahoe P, Swann D, Hayashi A, Sullivan. Mullerian Duct Regression in the Embryo Correlated with Cytotoxic Activity Against Human Ovarian Cancer Science. 205: 913-915. PMID 472712 DOI: 10.1126/Science.472712 |
0.323 |
|
| 1978 |
Bercu BB, Morikawa Y, Jackson IMD, Donahoe PK. Increased secretion of Müllerian inhibiting substance after immunological blockade of endogenous luteinizing hormone releasing hormone in the rat. Pediatric Research. 12: 139-142. PMID 347363 DOI: 10.1203/00006450-197802000-00015 |
0.325 |
|
| 1977 |
Donahoe PK, Ito Y, Hendren WH. A graded organ culture assay for the detection of mullerian inhibiting substance Journal of Surgical Research. 23: 141-148. PMID 886843 DOI: 10.1016/0022-4804(77)90202-5 |
0.333 |
|
| 1977 |
Price JM, Donahoe PK, Ito Y, Hendren WH. Programmed cell death in the Müllerian duct induced by Müllerian inhibiting substance. American Journal of Anatomy. 149: 353-375. PMID 879051 DOI: 10.1002/Aja.1001490304 |
0.353 |
|
| 1977 |
Ito Y, Donahoe PK, Hendren WH. Differentiation of intramural ganglia in the dissociated rectosigmoid of the rat: an organ culture study. Journal of Pediatric Surgery. 12: 969-975. PMID 592077 DOI: 10.1016/0022-3468(77)90608-X |
0.304 |
|
| 1977 |
Donahoe PK, Ito Y, Hendren WH. The preservation of Mullerian inhibiting substance during long-term freezing of testicular fragments. Cryobiology. 14: 534-542. PMID 561675 DOI: 10.1016/0011-2240(77)90163-8 |
0.314 |
|
| 1977 |
Donahoe PK, Ito Y, Price JM, Hendren WH. Müllerian Inhibiting Substance Activity in Bovine Fetal, Newborn and Prepubertal Testes Biology of Reproduction. 16: 238-243. PMID 556673 DOI: 10.1095/Biolreprod16.2.238 |
0.321 |
|
| 1977 |
Donahoe PK, Crawford JD, Hendren WH. Management of neonates and children with male pseudohermaphroditism. Journal of Pediatric Surgery. 12: 1045-57. PMID 338877 DOI: 10.1016/0022-3468(77)90617-0 |
0.304 |
|
| 1977 |
Donahoe PK, Ito Y, Morikawa Y, Hendren WH. Mullerian Inhibiting Substance in human testes after birth Journal of Pediatric Surgery. 12: 323-330. PMID 17665 DOI: 10.1016/0022-3468(77)90008-2 |
0.307 |
|
| 1976 |
Donahoe PK, Ito Y, Marfatia S, Hendren WH. The production of Mullerian inhibiting substance by the fetal, neonatal and adult rat. Biology of Reproduction. 15: 329-34. PMID 963157 DOI: 10.1095/Biolreprod15.3.329 |
0.319 |
|
| Show low-probability matches. |